Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies

BACKGROUND: Tumor angiogenesis is critical for tumor growth, infiltration and metastasis. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor and targeting it is important in reducing angiogenesis. Bevacizumab (Avastin), a monoclonal antibody that reacts directly against VEGF, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weina, Ran, Yonggang, Li, Meng, Zhang, Kuo, Qin, Xin, Xue, Xiaochang, Zhang, Cun, Hao, Qiang, Zhang, Wei, Zhang, Yingqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849980/
https://www.ncbi.nlm.nih.gov/pubmed/24073737
http://dx.doi.org/10.1186/1472-6750-13-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849980/
https://www.ncbi.nlm.nih.gov/pubmed/24073737
http://dx.doi.org/10.1186/1472-6750-13-77

Ejemplares similares